The study, which was reported in The New York Times (08/02/11), suggests that drugs used to treat severe post-traumatic stress symptoms have approximately the same effectiveness as placebos but also carry serious side effects. Published in The Journal of the American Medical Association, the study examined the use of Risperdal to treat veterans with post-traumatic stress symptoms. Risperdal, an antipsychotic medication, is in the same class of drugs as Abilify and Seroquel, leading experts to conclude that the same results could be found of Abilify.
Researchers found that veterans who were given Risperdal to treat post-traumatic stress had a similar recovery rate as those who were given a placebo. After six months of treatment, approximately five percent of veterans in both groups recovered and between 10 and 20 percent had some improvement, but had not fully recovered. This led researchers to conclude that treatment with the medication did not have an overall benefit for the veterans.
READ MORE ABILIFY LEGAL NEWS
The FDA noted that a search of the Adverse Event Reporting System (AERS) through October 29, 2008, found 69 cases of neonatal events, including abnormal muscle movements or withdrawal with all antipsychotic drugs. The agency reported that it was not known if the cause of the events were drug toxicity or drug withdrawal. Onset of symptoms ranged from birth to one month after birth. According to the FDA, some infants recovered on their own, while others required intensive care and prolonged hospitalization.
Women who take Abilify and are pregnant or planning on becoming pregnant should discuss their options with their doctor.